Alpesh Patel, Cfa
About Alpesh Patel, Cfa
Alpesh Patel is the Chief Financial Officer at InfuCare Rx, with extensive experience in financial valuation and analysis. He previously held senior positions at Valuation Research Corporation and has a strong educational background in finance and economics.
Current Role at InfuCare Rx
Alpesh Patel serves as the Chief Financial Officer at InfuCare Rx, a position he has held since 2015. In this role, he oversees the financial operations of the company, contributing to its strategic financial planning and decision-making processes. His tenure at InfuCare Rx has been marked by a focus on enhancing financial performance and ensuring compliance with industry standards. Located in the Greater New York City Area, Patel's leadership is integral to the company's financial health.
Previous Experience at VRC
Prior to his current role, Alpesh Patel worked at Valuation Research Corporation (VRC) for a total of 14 years. He began as a Summer Analyst in 2004, later advancing to Senior Vice President from 2005 to 2018, and then serving as Managing Director for one year in 2019. His extensive experience at VRC involved the valuation of complex financial instruments, including mezzanine debt and distressed debt, which provided him with a solid foundation in financial analysis and valuation.
Education and Expertise
Alpesh Patel holds a Bachelor of Science degree in Finance and Economics from Penn State University, where he studied from 2001 to 2005. He furthered his education by obtaining the Chartered Financial Analyst (CFA) designation from the CFA Institute, completing the program from 2005 to 2007. His educational background supports his expertise in evaluating venture capital investments and convertible preferred securities, as well as private equity valuation.
Specialized Skills in Financial Valuation
Patel possesses specialized skills in the valuation of complex financial instruments. His expertise includes evaluating mezzanine debt, distressed debt, venture capital investments, and convertible preferred securities. This skill set enables him to contribute effectively to strategic financial decision-making, particularly in areas related to private equity valuation.